{"key":"op_714_ES","page":{"url":"https://ru.bookimed.com/clinics/country=spain/procedure=immunoterapia-pri-rake-pocki/","procedure":{"id":714,"slug":"immunoterapia-pri-rake-pocki","name":"Иммунотерапия при раке почки","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":34,"iso":"ES","name":"Испания"},"currency":"USD","data_date":"2026-09-25"},"pages":{"clinics_url":"https://ru.bookimed.com/clinics/country=spain/procedure=immunoterapia-pri-rake-pocki/","cost_url":"https://ru.bookimed.com/clinics/country=spain/procedure=immunoterapia-pri-rake-pocki/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":2200,"to":18000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":60000,"to":160000},"uk":{"from":38000,"to":68000},"by_technique":{"status":"missing","reason":"not_collected"},"by_city":[{"city":"Барселона","from":2200},{"city":"Памплона","from":7800},{"city":"Аликанте","from":14000},{"city":"Мадрид","from":6000}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":9000,"to":22000},{"country_iso":"FR","from":14000,"to":30000},{"country_iso":"GB","from":38000,"to":68000},{"country_iso":"US","from":60000,"to":160000},{"country_iso":"IL","from":38000,"to":58000},{"country_iso":"TR","from":8000,"to":25000},{"country_iso":"MX","from":18000,"to":36000},{"country_iso":"DE","from":9500,"to":18500},{"country_iso":"CA","from":42000,"to":85000},{"country_iso":"AE","from":28000,"to":55000},{"country_iso":"TH","from":5900,"to":32000},{"country_iso":"PL","from":14000,"to":32000},{"country_iso":"KR","from":9000,"to":20000},{"country_iso":"CZ","from":9000,"to":20000},{"country_iso":"AT","from":28000,"to":48000},{"country_iso":"IT","from":18000,"to":34000},{"country_iso":"CN","from":9000,"to":22000},{"country_iso":"AU","from":18000,"to":40000},{"country_iso":"IN","from":14000,"to":24000},{"country_iso":"MY","from":15000,"to":29000},{"country_iso":"VN","from":9000,"to":19000},{"country_iso":"BR","from":22000,"to":38000},{"country_iso":"EG","from":1500,"to":25000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":96,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":6,"items":[{"id":6225,"name":"Hospital Ruber Internacional","city":"Madrid","rating":5,"reviews_count":3,"accreditations":["Joint Commission International","International Organization for Standardization"],"rank":1,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":78,"name":"Centro Médico Teknon","city":"Barcelona","rating":4.7,"reviews_count":498,"accreditations":["Joint Commission International","European Foundation for Quality Management","THE IMTJ MEDICAL TRAVEL AWARD WINNER IN 2019","Patient choice in Neurology","Patient choice in Neurosurgery","Patient choice for Epilepsy treatment","World's Best Hospitals 2021 by Newsweek"],"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":272,"name":"SJD Barcelona Children’s Hospital","city":"Barcelona","rating":4.7,"reviews_count":44,"accreditations":["Bookimed Award: Best pediatric hospital","World's Best Specialized Hospitals 2022 by Newsweek"],"rank":3,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":339,"name":"Clinica Universidad de Navarra (Navarra Hospital)","city":"Pamplona","rating":4.7,"reviews_count":7,"accreditations":["Joint Commission International","European Society for Medical Oncology","World's Best Hospitals 2020 by Newsweek","World's Best Hospitals 2021 by Newsweek","World's Best Smart Hospitals 2021 by Newsweek","World's Best Hospitals 2022 by Newsweek","World's Best Smart Hospitals 2023 by Newsweek"],"rank":4,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":422,"name":"Hospital HM Nou Delfos","city":"Barcelona","rating":4.6,"reviews_count":5,"accreditations":["European Foundation for Quality Management","Certification according to DIN EN ISO 9001 by TÜV NORD CERT"],"rank":5,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":953,"name":"GenesisCare Clinics","city":"Madrid","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":{"status":"missing","reason":"not_collected"},"rank":6,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":{"status":"missing","reason":"not_collected"},"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":98,"slug":"barselona","name":"Барселона","clinics_count":1,"price_from":2200,"profile":{"city_type":"Mediterranean coastal city in Spain","access":["Barcelona Airport (BCN), 15 km southwest of city center"],"sources":["https://en.wikipedia.org/wiki/Barcelona","https://en.wikipedia.org/wiki/Barcelona–El_Prat_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":366,"slug":"pamplona","name":"Памплона","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":7800,"profile":{"status":"missing","reason":"not_collected"}},{"id":441,"slug":"alicante","name":"Аликанте","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":14000,"profile":{"city_type":"Mediterranean port city in Spain","access":["Alicante Airport (ALC), 9 km from the city"],"sources":["https://en.wikipedia.org/wiki/Alicante","https://en.wikipedia.org/wiki/Alicante%E2%80%93Elche_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":346,"slug":"madrid","name":"Мадрид","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":6000,"profile":{"city_type":"Capital and largest city of Spain","access":["Madrid Barajas Airport (MAD), 13 km from Puerta del Sol"],"sources":["https://en.wikipedia.org/wiki/Madrid","https://en.wikipedia.org/wiki/Madrid–Barajas_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Advanced or metastatic renal cell carcinoma","Adjuvant pembrolizumab after nephrectomy for higher-risk clear-cell carcinoma"],"contraindications":["Active uncontrolled autoimmune disease","Prior severe immune-related reaction to checkpoint inhibitors","Organ transplant recipient on immunosuppression","Systemic steroids above 10 mg prednisone daily","Active uncontrolled infection","Untreated symptomatic brain metastases","Pregnancy or breastfeeding","Poor performance status (ECOG 3-4)","Significant heart, lung or liver dysfunction (for interleukin-2)"],"operation_hours":{"min":1,"max":3,"unit":"hours","qualifier":"Per infusion visit including check-in, blood tests and observation; infusion itself is 30-90 minutes."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":4,"max":35,"unit":"visits","qualifier":"Infusions every 2-6 weeks for months; total depends on regimen, response and tolerance."},"stages":[{"code":"baseline_assessment","label":"Baseline scans, tests and eligibility check","after":{"min":0,"max":0,"unit":"days","qualifier":"Before the first infusion."}},{"code":"induction_infusions","label":"Initial combination infusion cycles","after":{"min":0,"max":0,"unit":"days","qualifier":"Starts at the first infusion; four cycles given every 3 weeks."}},{"code":"response_scan","label":"First response imaging","after":{"min":56,"max":84,"unit":"days","qualifier":"Repeated every 2-3 months."}},{"code":"maintenance_infusions","label":"Maintenance infusions","after":{"min":84,"max":730,"unit":"days","qualifier":"Continues while benefit persists and side effects are tolerable."}}],"qualifier":"Regimen-dependent; infusions repeat for months, with scans between."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Infusions are given as day visits; hospital admission is needed only for severe side effects."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":1,"max":3,"unit":"days","qualifier":"Recovery after each infusion depends on fatigue and any immune-related side effects."},"fly_home_after_days":{"min":0,"max":1,"unit":"days","qualifier":"Same or next day after an infusion without reactions, per oncologist clearance."},"back_to_work_days":{"min":1,"max":3,"unit":"days","qualifier":"Many patients work between cycles; fatigue and side effects determine time off after each infusion."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity is usually encouraged; intensity depends on fatigue and side effects."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Response is judged by scans every 8-12 weeks; some responses deepen over longer treatment."},"result_longevity":"Duration varies; responses can last months to years, and some are durable after stopping treatment. Others progress and need a change of therapy.","main_risks":["Serious immune-related reactions in skin, bowel, liver, lungs, glands, kidneys.","Infusion reactions and fatigue.","Higher toxicity with combination regimens, including targeted agents.","High-dose interleukin-2: capillary leak, hypotension, organ toxicity."],"complication_rate_pct":{"min":55,"max":95,"unit":"percent","qualifier":"Any-grade treatment-related adverse events; highest with dual checkpoint blockade."},"revision_rate_pct":{"min":15,"max":30,"unit":"percent","qualifier":"Share of patients who stop or change regimen due to toxicity; varies by regimen."},"success":{"metric":"Objective response rate (tumor shrinkage on scans)","value":42,"horizon":"Within 3-6 months of starting treatment","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"None; no incisions.","pain":"Infusions are painless apart from the needle prick. Side effects such as joint pain, headache or abdominal discomfort may occur.","preparation":["Baseline CT or MRI scans","Blood tests: kidney, liver, thyroid, cortisol","Screening for hepatitis and infections","Review of autoimmune history and medications","Review of pathology and risk group","Discussion of side-effect warning signs","Arrange local emergency oncology contact"],"recovery_timeline":[{"phase":"Infusion day","description":"Infusion lasts under 2 hours, with observation for reactions. Most patients leave the same day.","restrictions":["Avoid driving if feeling unwell"]},{"phase":"Days 1-7 after infusion","description":"Fatigue, mild rash, diarrhea or flu-like symptoms may occur. Report new symptoms promptly.","restrictions":["Do not self-treat persistent diarrhea or rash","Stay near medical care"]},{"phase":"Weeks 2-12","description":"Cycles repeat every 2-4 weeks with blood tests. Immune side effects can appear at any time.","restrictions":["Avoid new supplements without approval"]},{"phase":"Months 3-6","description":"Response scans guide continuation. Late immune side effects remain possible after treatment.","restrictions":{"status":"missing","reason":"not_collected"}}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"Clinical review and blood tests before each cycle, often at home."}},{"purpose":"result_review","requirement":"routine","after":{"min":56,"max":84,"unit":"days","qualifier":"First response CT or MRI, then repeated every 2-3 months."}},{"purpose":"other","requirement":"conditional","after":{"min":7,"max":90,"unit":"days","qualifier":"Evaluation and treatment of suspected immune-related side effects."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check the clinician's qualifications and the facility's credentials before choosing a provider","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"Check the qualifications of the clinician who will be doing the procedure and the credentials of the facility where the procedure will be done.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check how aftercare will be coordinated","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Check that you understand the possible complications and side effects of the treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Make sure you understand the possible complications and side effects that could arise from your treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Check the facility's infection control practices, since drug-resistant infection is a risk abroad","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"Healthcare facilities in another country may not have adequate infection control practices and medical tourists could be at risk for getting a drug-resistant infection.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Check how you will communicate with the clinicians caring for you if you do not speak the language","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"If you go to a country where you do not speak the language, determine ahead of time how you will communicate with your clinician and others who will be caring for you.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C6","text":"Check that the treatment plan accounts for kidney cancer type and stage, overall health, and kidney function","scope":"procedure","source":{"url":"https://www.kidney.org/kidney-topics/kidney-cancer-treatment-and-living-well","host":"kidney.org","quote":"Doctors decide which medicine to use based on the type and stage of kidney cancer, your overall health, and how well your kidneys are working.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to make a quick decision is a warning sign before booking treatment abroad","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"a hard sell a lack of information pressure to make a quick decision no discussion of possible complications no mention of aftercare","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F2","text":"You cannot ask the team questions about your treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F3","text":"The clinic cannot explain how aftercare will be coordinated after you return home","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Severe allergic reaction","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"Some types of immunotherapy may cause severe or fatal allergic and inflammation-related reactions.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Shortness of breath","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Inflammation in the lungs, called pneumonitis , can cause you to feel short of breath and have a bad cough.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Blood in urine","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"You may see blood in your urine.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W4","text":"Decreased urine production","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Kidney inflammation, called nephritis , may decrease the amount of urine you produce.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"It gives the home doctor the follow-up recommendations for continuing care","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/our-health-board/our-standards-and-duties/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad/","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"T2","text":"It shows the cancer stage the home doctor needs for follow-up","document":"pathology report","source":{"url":"https://www.cancer.gov/types/kidney/patient/kidney-treatment-pdq","host":"cancer.gov","quote":"The cancer may be described by this staging system in your pathology report.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"T3","text":"It tells the home doctor medicines and doses to continue or review","document":"medication list","source":{"url":"https://sbuhb.nhs.wales/about-us/our-health-board/our-standards-and-duties/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad/","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"T4","text":"It provides blood-test and follow-up dates needed for continuing care","document":"aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/our-health-board/our-standards-and-duties/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad/","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"preop_tests":{"status":"missing","reason":"not_collected"},"prep_in_advance":{"status":"missing","reason":"not_collected"},"visit_and_day":{"status":"missing","reason":"not_collected"},"if_something_changes":{"status":"missing","reason":"not_collected"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":1,"max":3,"unit":"days","qualifier":"Many patients work between cycles; fatigue and side effects determine time off after each infusion."},"complication_rate_pct":{"min":55,"max":95,"unit":"percent","qualifier":"Any-grade treatment-related adverse events; highest with dual checkpoint blockade."},"contraindications":["Active uncontrolled autoimmune disease","Prior severe immune-related reaction to checkpoint inhibitors","Organ transplant recipient on immunosuppression","Systemic steroids above 10 mg prednisone daily","Active uncontrolled infection","Untreated symptomatic brain metastases","Pregnancy or breastfeeding","Poor performance status (ECOG 3-4)","Significant heart, lung or liver dysfunction (for interleukin-2)"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Infusions are given as day visits; hospital admission is needed only for severe side effects."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity is usually encouraged; intensity depends on fatigue and side effects."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Response is judged by scans every 8-12 weeks; some responses deepen over longer treatment."},"fly_home_after_days":{"min":0,"max":1,"unit":"days","qualifier":"Same or next day after an infusion without reactions, per oncologist clearance."},"follow_up_visits":[{"purpose":"assessment","after":{"min":14,"max":28,"unit":"days","qualifier":"Clinical review and blood tests before each cycle, often at home."},"requirement":"routine"},{"purpose":"result_review","after":{"min":56,"max":84,"unit":"days","qualifier":"First response CT or MRI, then repeated every 2-3 months."},"requirement":"routine"},{"purpose":"other","after":{"min":7,"max":90,"unit":"days","qualifier":"Evaluation and treatment of suspected immune-related side effects."},"requirement":"conditional"}],"indications":["Advanced or metastatic renal cell carcinoma","Adjuvant pembrolizumab after nephrectomy for higher-risk clear-cell carcinoma"],"main_risks":["Serious immune-related reactions in skin, bowel, liver, lungs, glands, kidneys.","Infusion reactions and fatigue.","Higher toxicity with combination regimens, including targeted agents.","High-dose interleukin-2: capillary leak, hypotension, organ toxicity."],"pain":"Infusions are painless apart from the needle prick. Side effects such as joint pain, headache or abdominal discomfort may occur.","preparation":["Baseline CT or MRI scans","Blood tests: kidney, liver, thyroid, cortisol","Screening for hepatitis and infections","Review of autoimmune history and medications","Review of pathology and risk group","Discussion of side-effect warning signs","Arrange local emergency oncology contact"],"recovery_timeline":[{"phase":"Infusion day","description":"Infusion lasts under 2 hours, with observation for reactions. Most patients leave the same day.","restrictions":["Avoid driving if feeling unwell"]},{"phase":"Days 1-7 after infusion","description":"Fatigue, mild rash, diarrhea or flu-like symptoms may occur. Report new symptoms promptly.","restrictions":["Do not self-treat persistent diarrhea or rash","Stay near medical care"]},{"phase":"Weeks 2-12","description":"Cycles repeat every 2-4 weeks with blood tests. Immune side effects can appear at any time.","restrictions":["Avoid new supplements without approval"]},{"phase":"Months 3-6","description":"Response scans guide continuation. Late immune side effects remain possible after treatment.","restrictions":[]}],"rehabilitation_days":{"min":1,"max":3,"unit":"days","qualifier":"Recovery after each infusion depends on fatigue and any immune-related side effects."},"result_longevity":"Duration varies; responses can last months to years, and some are durable after stopping treatment. Others progress and need a change of therapy.","revision_rate_pct":{"min":15,"max":30,"unit":"percent","qualifier":"Share of patients who stop or change regimen due to toxicity; varies by regimen."},"scars":"None; no incisions.","sessions_or_stages":{"sessions":{"min":4,"max":35,"unit":"visits","qualifier":"Infusions every 2-6 weeks for months; total depends on regimen, response and tolerance."},"stages":[{"code":"baseline_assessment","label":"Baseline scans, tests and eligibility check","after":{"min":0,"max":0,"unit":"days","qualifier":"Before the first infusion."}},{"code":"induction_infusions","label":"Initial combination infusion cycles","after":{"min":0,"max":0,"unit":"days","qualifier":"Starts at the first infusion; four cycles given every 3 weeks."}},{"code":"response_scan","label":"First response imaging","after":{"min":56,"max":84,"unit":"days","qualifier":"Repeated every 2-3 months."}},{"code":"maintenance_infusions","label":"Maintenance infusions","after":{"min":84,"max":730,"unit":"days","qualifier":"Continues while benefit persists and side effects are tolerable."}}],"qualifier":"Regimen-dependent; infusions repeat for months, with scans between."},"success":{"metric":"Objective response rate (tumor shrinkage on scans)","value":42,"unit":"percent of patients","horizon":"Within 3-6 months of starting treatment","population":"Adults with advanced or metastatic renal cell carcinoma on first-line checkpoint inhibitor combination","evidence_status":"limited"},"techniques":[{"name":"Immune checkpoint inhibitor combination (for example anti-PD-1 plus anti-CTLA-4)","suits_whom":"Selected patients with advanced renal cell carcinoma, usually intermediate or poor risk, under regimen-specific approval.","recovery":"Given as intravenous infusions. Recovery and schedule vary by regimen and side effects."},{"name":"Checkpoint inhibitor plus a VEGF-targeted tyrosine kinase inhibitor","suits_whom":"Selected patients with advanced renal cell carcinoma across risk groups, depending on the regimen.","recovery":"Combines infusions with daily oral therapy. Recovery and schedule vary."},{"name":"Adjuvant checkpoint inhibitor after nephrectomy","suits_whom":"Selected patients at higher risk of recurrence after surgery, where approved.","recovery":"Given as intravenous infusions after surgical recovery. Schedule varies by regimen."},{"name":"High-dose interleukin-2","suits_whom":"Rarely used; for highly selected fit patients with metastatic disease at specialist centers.","recovery":"Requires inpatient monitoring, and recovery varies."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":1,"max":3,"unit":"hours","qualifier":"Per infusion visit including check-in, blood tests and observation; infusion itself is 30-90 minutes."},"initial_assessment_documents":["Kidney biopsy or nephrectomy pathology report","Recent CT or MRI scans with reports","Previous oncologist treatment summary","Recent blood tests including kidney and thyroid function","List of autoimmune conditions and current medications"],"travel_trips":{"min":2,"max":4,"one_trip_possible":false,"qualifier":"Trips last one to three days; later cycles and scans often done at home."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check the clinician's qualifications and the facility's credentials before choosing a provider","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"Check the qualifications of the clinician who will be doing the procedure and the credentials of the facility where the procedure will be done.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check how aftercare will be coordinated","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Check that you understand the possible complications and side effects of the treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Make sure you understand the possible complications and side effects that could arise from your treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Check the facility's infection control practices, since drug-resistant infection is a risk abroad","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"Healthcare facilities in another country may not have adequate infection control practices and medical tourists could be at risk for getting a drug-resistant infection.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Check how you will communicate with the clinicians caring for you if you do not speak the language","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"If you go to a country where you do not speak the language, determine ahead of time how you will communicate with your clinician and others who will be caring for you.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C6","text":"Check that the treatment plan accounts for kidney cancer type and stage, overall health, and kidney function","scope":"procedure","source":{"url":"https://www.kidney.org/kidney-topics/kidney-cancer-treatment-and-living-well","host":"kidney.org","quote":"Doctors decide which medicine to use based on the type and stage of kidney cancer, your overall health, and how well your kidneys are working.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to make a quick decision is a warning sign before booking treatment abroad","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"a hard sell a lack of information pressure to make a quick decision no discussion of possible complications no mention of aftercare","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F2","text":"You cannot ask the team questions about your treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F3","text":"The clinic cannot explain how aftercare will be coordinated after you return home","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Severe allergic reaction","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"Some types of immunotherapy may cause severe or fatal allergic and inflammation-related reactions.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Shortness of breath","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Inflammation in the lungs, called pneumonitis , can cause you to feel short of breath and have a bad cough.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Blood in urine","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"You may see blood in your urine.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W4","text":"Decreased urine production","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Kidney inflammation, called nephritis , may decrease the amount of urine you produce.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"It gives the home doctor the follow-up recommendations for continuing care","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/our-health-board/our-standards-and-duties/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad/","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"T2","text":"It shows the cancer stage the home doctor needs for follow-up","document":"pathology report","source":{"url":"https://www.cancer.gov/types/kidney/patient/kidney-treatment-pdq","host":"cancer.gov","quote":"The cancer may be described by this staging system in your pathology report.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"T3","text":"It tells the home doctor medicines and doses to continue or review","document":"medication list","source":{"url":"https://sbuhb.nhs.wales/about-us/our-health-board/our-standards-and-duties/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad/","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"T4","text":"It provides blood-test and follow-up dates needed for continuing care","document":"aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/our-health-board/our-standards-and-duties/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad/","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your kidney cancer is found early and has not spread","name":"Kidney cancer surgery","source":{"url":"https://www.nhs.uk/conditions/kidney-cancer/treatment/","host":"nhs.uk","quote":"If kidney cancer is found early and it has not spread, you may be able to have surgery to remove it.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null},{"id":"A2","text":"The cancer is small and you're too unwell to have surgery","name":"Radiofrequency ablation","source":{"url":"https://www.nhs.uk/conditions/kidney-cancer/treatment/","host":"nhs.uk","quote":"the cancer is small and you're too unwell to have surgery to remove it","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":116},{"id":"A3","text":"The cancer cannot be removed by surgery","name":"Radiotherapy","source":{"url":"https://www.nhs.uk/conditions/kidney-cancer/treatment/","host":"nhs.uk","quote":"the cancer cannot be removed by surgery","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":140}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"technique_details":{"status":"ok","items":[{"id":"immune-checkpoint-inhibitor","name":"Immune checkpoint inhibitor combination (for example anti-PD-1 plus anti-CTLA-4)","how_it_works":{"text":"Checkpoint inhibitors strengthen the immune system's response to cancer","source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Immunotherapy is a type of cancer treatment that strengthens your immune system’s response to cancer.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"checkpoint-inhibitor","name":"Checkpoint inhibitor plus a VEGF-targeted tyrosine kinase inhibitor","how_it_works":{"text":"A checkpoint inhibitor and targeted drug are combined for kidney cancer","source":{"url":"https://www.cancer.gov/types/kidney/research","host":"cancer.gov","quote":"p embrolizumab (Keytruda), plus the targeted drug axitinib (Inlyta)","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"adjuvant-checkpoint","name":"Adjuvant checkpoint inhibitor after nephrectomy","how_it_works":{"text":"Immunotherapy is given after surgery to help people live longer","source":{"url":"https://www.cancer.gov/types/kidney/research","host":"cancer.gov","quote":"But recently, a large study found that giving the immunotherapy drug pembrolizumab (Keytruda) after surgery helped people with clear-cell renal cancer at high risk of recurrence live longer","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"high-dose-interleukin-2","name":"High-dose interleukin-2","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"preop_tests":null,"prep_in_advance":null,"visit_and_day":null,"if_something_changes":null}},"techniques":[{"id":"immune-checkpoint-inhibitor","name":"Immune checkpoint inhibitor combination (for example anti-PD-1 plus anti-CTLA-4)","how_it_works":{"id":"H1","text":"Checkpoint inhibitors strengthen the immune system's response to cancer","source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Immunotherapy is a type of cancer treatment that strengthens your immune system’s response to cancer.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected patients with advanced renal cell carcinoma, usually intermediate or poor risk, under regimen-specific approval.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Given as intravenous infusions. Recovery and schedule vary by regimen and side effects."},{"id":"checkpoint-inhibitor","name":"Checkpoint inhibitor plus a VEGF-targeted tyrosine kinase inhibitor","how_it_works":{"id":"H1","text":"A checkpoint inhibitor and targeted drug are combined for kidney cancer","source":{"url":"https://www.cancer.gov/types/kidney/research","host":"cancer.gov","quote":"p embrolizumab (Keytruda), plus the targeted drug axitinib (Inlyta)","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected patients with advanced renal cell carcinoma across risk groups, depending on the regimen.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Combines infusions with daily oral therapy. Recovery and schedule vary."},{"id":"adjuvant-checkpoint","name":"Adjuvant checkpoint inhibitor after nephrectomy","how_it_works":{"id":"H1","text":"Immunotherapy is given after surgery to help people live longer","source":{"url":"https://www.cancer.gov/types/kidney/research","host":"cancer.gov","quote":"But recently, a large study found that giving the immunotherapy drug pembrolizumab (Keytruda) after surgery helped people with clear-cell renal cancer at high risk of recurrence live longer","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected patients at higher risk of recurrence after surgery, where approved.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Given as intravenous infusions after surgical recovery. Schedule varies by regimen."},{"id":"high-dose-interleukin-2","name":"High-dose interleukin-2","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Rarely used; for highly selected fit patients with metastatic disease at specialist centers.","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Requires inpatient monitoring, and recovery varies."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your kidney cancer is found early and has not spread","name":"Kidney cancer surgery","source":{"url":"https://www.nhs.uk/conditions/kidney-cancer/treatment/","host":"nhs.uk","quote":"If kidney cancer is found early and it has not spread, you may be able to have surgery to remove it.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null},{"id":"A2","text":"The cancer is small and you're too unwell to have surgery","name":"Radiofrequency ablation","source":{"url":"https://www.nhs.uk/conditions/kidney-cancer/treatment/","host":"nhs.uk","quote":"the cancer is small and you're too unwell to have surgery to remove it","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":116},{"id":"A3","text":"The cancer cannot be removed by surgery","name":"Radiotherapy","source":{"url":"https://www.nhs.uk/conditions/kidney-cancer/treatment/","host":"nhs.uk","quote":"the cancer cannot be removed by surgery","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":140}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"passport_validity","audience":"uk","volatile":true,"text":"The passport must have an expiry date at least 3 months after you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"medicines","audience":"all","volatile":false,"text":"Carry prescription medication in its original packaging, along with your doctor's prescription","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Always carry your prescription medication in original packaging, along with your doctor’s prescription.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"prescriptions","audience":"us","volatile":false,"text":"Medications that require a prescription in the United States also require a local doctor's prescription in Spain","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Medications requiring prescriptions in the United States also require a local doctor’s prescription in Spain.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V4","item":"ghic","audience":"uk","volatile":false,"text":"A GHIC or EHIC is needed to get medically necessary state healthcare in Spain","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Spain, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V5","item":"hospital_payment","audience":"all","volatile":false,"text":"Private hospitals usually require payment or proof of insurance or funds before admitting a patient","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Private hospitals usually require payment or proof insurance or funds before admitting a patient.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["azerbaijan","china","germany","greece","india","israel","latvia","malaysia","mexico","republic-of-korea","switzerland","thailand","turkey","ukraine"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.7,"count":557,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Immunotherapy for kidney cancer in Spain typically costs from _op_714_price_from_ to _op_714_price_to_. This price range often covers a single treatment cycle or initial diagnostic phase. In the US, this procedure costs _price_compare_US_average_ on average. Final expenses depend on the specific medication protocols and clinic tier in major medical hubs like Madrid, Barcelona, and Pamplona.</p>\n\n<ul>\n<li><strong>Medication type.</strong> Costs vary significantly between single-drug monotherapy and advanced dual checkpoint inhibitor combinations.</li>\n<li><strong>Treatment frequency.</strong> Total budgeting must account for the number of prescribed infusion cycles.</li>\n<li><strong>Hospital location.</strong> Premier private facilities in Barcelona and Madrid often maintain higher pricing structures.</li>\n<li><strong>Diagnostic requirements.</strong> Pre-treatment molecular testing and advanced imaging like 3-Tesla MRI influence the total bill.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight.</strong> Spanish oncology centers offer high-tier clinical care at more accessible price points. For example, Centro Médico Teknon in Barcelona provides immunotherapy starting around $2,200. This clinic holds JCI accreditation and is part of the extensive Quirónsalud network. Facilities like Clinica Universidad de Navarra are also recognized globally by Newsweek. Patients receive care in hospitals that treat thousands of international cases annually.</p>","faq":[{"q":"What are the side effects of kidney cancer immunotherapy?","a":"<p>Kidney cancer immunotherapy side effects occur when the immune system attacks healthy cells. Common reactions include persistent fatigue, skin rashes, itching, and gastrointestinal issues like diarrhea. Serious inflammation can also affect the lungs, liver, or endocrine system, sometimes requiring lifelong hormone replacement therapy.</p> <ul> <li><strong>Endocrine dysfunction:</strong> Thyroid issues like hypothyroidism often become permanent, lifelong conditions requiring daily medication.</li> <li><strong>Gastrointestinal distress:</strong> Severe colitis may cause bloody stools and require hospitalization or steroid therapy.</li> <li><strong>Dermatological reactions:</strong> Persistent itching, especially in the lower legs, often continues after treatment concludes.</li> <li><strong>Organ inflammation:</strong> Rare but serious inflammation can impact the heart, kidneys, or liver function.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain’s oncology centers, including JCI-accredited Hospital Ruber Internacional and Centro Médico Teknon, use advanced monitoring for inflammatory markers. Many patients worry about visible side effects. However, our data analysis suggests a potential correlation between immune-related reactions and a robust anti-tumor response.</p> <p><strong>Patient Consensus:</strong> While most patients manage side effects with steroids, many report deep, ongoing exhaustion. They often emphasize the importance of monitoring bowel changes or skin sensitivity daily.</p>"},{"q":"What immunotherapy options are available for kidney cancer in Spain?","a":"<p>Immunotherapy for kidney cancer in Spain includes advanced immune checkpoint inhibitors like Pembrolizumab (Keytruda), Nivolumab (Opdivo), and Ipilimumab (Yervoy). These treatments are available at JCI-accredited centers in Madrid and Barcelona, following EMA protocols for metastatic or high-risk renal cell carcinoma management.</p> <ul> <li><strong>Main immunotherapy drugs:</strong> Keytruda, Opdivo, and Yervoy are the primary pharmacological options used.</li> <li><strong>Treatment combinations:</strong> Surgeons often pair Nivolumab with Ipilimumab for intermediate-risk advanced cases.</li> <li><strong>Adjuvant therapy:</strong> Pembrolizumab infusions help reduce recurrence risk for high-risk patients post-surgery.</li> <li><strong>Accredited facilities:</strong> Clinics like Centro Médico Teknon and Hospital Ruber Internacional provide these therapies.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spanish oncology centers like Clínica Universidad de Navarra offer a unique level of safety as the first in Spain to hold JCI accreditation. Patients seeking immunotherapy here benefit from multidisciplinary teams that manage complex immune-related side effects using protocols from the European Society for Medical Oncology.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the need to monitor side effects like colitis closely during the year-long infusion schedule. Many recommend scheduling travel with 2–3 week buffers to handle post-treatment recovery comfortably.</p>"},{"q":"Will Spanish public insurance (Seguridad Social) cover immunotherapy?","a":"<p>Spanish public insurance (Seguridad Social) covers immunotherapy for kidney cancer when deemed medically necessary. The system includes advanced biologics administered through hospital pharmacies. Patients must be registered residents with a referral from a primary doctor to a specialist to access these protocols at no direct cost.</p> <ul> <li><strong>Coverage eligibility:</strong> Residency and active contributions to the Spanish health system are required for access.</li> <li><strong>Hospital pharmacy:</strong> Biologic drugs are provided directly by hospitals, eliminating high out-of-pocket retail costs.</li> <li><strong>Standard protocol:</strong> Immunotherapy is included in national oncology guidelines for advanced or metastatic cancer stages.</li> <li><strong>Specialist referral:</strong> Treatment approval follows a strict pathway from primary care to oncology departments.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain hosts world-class oncology centers like Centro Medico Teknon and Clinica Universidad de Navarra, which often lead clinical trials. While public insurance covers standard immunotherapy, these JCI-accredited private facilities provide faster access to the latest AI-driven diagnostics and robotic surgery. Choosing a top-ranked facility ensures a comprehensive approach that balances public coverage with elite private technology.</p> <p><strong>Patient Consensus:</strong> Patients emphasize focusing on medical staging rather than finances since drugs are fully covered. Many recommend consulting hospital social workers to navigate administrative steps or access integrated support for side effects like fatigue.</p>"},{"q":"How often will I get immunotherapy treatment in Spain?","a":"<p>Immunotherapy for kidney cancer in Spain typically follows a 3-week or 6-week schedule depending on your specific protocol. Doctors often administer treatments like Pembrolizumab over 1 year or in 6-cycle blocks at JCI-accredited centers in Madrid and Barcelona to ensure optimal patient response.</p> <ul> <li><strong>Standard frequency:</strong> Patients receive infusions every 3 to 6 weeks based on dosage.</li> <li><strong>Treatment duration:</strong> Most protocols for kidney cancer last approximately 1 year total.</li> <li><strong>Infusion cycles:</strong> Sessions often occur in 6 cycles to monitor drug efficacy.</li> <li><strong>Administration method:</strong> Specialists provide medications intravenously during outpatient visits at specialized oncology units.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Clinics like Hospital Ruber Internacional and Centro Médico Teknon often provide 400mg doses every 6 weeks. This extended cycle is ideal for international patients. It reduces the number of trips required compared to the standard 200mg dose given every 3 weeks.</p> <p><strong>Patient Consensus:</strong> Patients recommend completing at least 4 infusions before traveling extensively. This helps stabilize potential side effects like thyroid issues, which are manageable with daily medication.</p>"},{"q":"Are clinical trials for kidney cancer immunotherapy available in Spain?","a":"<p>Spain offers active clinical trials for kidney cancer immunotherapy, particularly focusing on Phase II anti-PD1 agents and checkpoint inhibitors. Leading JCI-accredited centers in Madrid and Barcelona investigate advanced therapies like pembrolizumab for high-risk relapse cases and metastatic renal cell carcinoma under European Medicines Agency protocols.</p> <ul> <li><strong>Available protocols:</strong> Access includes Phase II clinical trials and post-surgical adjuvant immunotherapy pathways.</li> <li><strong>Leading institutions:</strong> Research occurs at Hospital Ruber Internacional, Centro Médico Teknon, and Hospital HM Nou Delfos.</li> <li><strong>Standard therapy:</strong> Adjuvant pembrolizumab is frequently prescribed for high-risk patients following a nephrectomy.</li> <li><strong>Monitoring schedule:</strong> Patients typically undergo diagnostic scans every 3 to 6 months to monitor recurrence.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain’s research network is exceptionally integrated, with centers like Clinica Universidad de Navarra holding European Society for Medical Oncology accreditation. Data shows patients often access trials here when standard therapies fail. Smart patients seek genetic testing in Spanish labs to refine their immunotherapy eligibility early.</p> <p><strong>Patient Consensus:</strong> Many patients find these trials accessible a few weeks after surgery. They highlight the importance of discussing tumor risk features, such as vena cava involvement, with an oncologist to secure enrollment.</p>"},{"q":"Where can I receive immunotherapy for kidney cancer in Spain?","a":"<p>Patients can receive immunotherapy for kidney cancer in Spain at JCI-accredited oncology centers in Madrid, Barcelona, and Pamplona. Clinics like Centro Médico Teknon and Clínica Universidad de Navarra provide advanced adjuvant therapies, including Pembrolizumab infusions, following nephrectomy for high-risk renal cell carcinoma cases.</p> <ul> <li><strong>Available clinics:</strong> Madrid hosts Hospital Ruber Internacional, while Barcelona offers Centro Médico Teknon.</li> <li><strong>Accreditation standards:</strong> Facilities maintain Joint Commission International (JCI) and ESMO oncology certifications.</li> <li><strong>Treatment schedule:</strong> Infusions typically occur every 3 to 6 weeks for one year.</li> <li><strong>Clinical approach:</strong> Adjuvant immunotherapy specifically targets high-risk patients to prevent cancer recurrence.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While major centers in Madrid and Barcelona are popular, Clínica Universidad de Navarra stands out for global recognition. It was the first Spanish hospital to earn JCI accreditation and consistently ranks in Newsweek’s Best Specialized Hospitals. For patients seeking the highest safety benchmarks, this facility offers an elite 400-bed infrastructure dedicated to complex oncology.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that treatment starts a few weeks after surgery. Many report that managing side effects like fatigue or nausea is easier with direct, consistent communication with their oncological team.</p>"}],"h2":[{"text":"Как это работает","kind":"content"},{"text":"Какая цена иммунотерапии при раке почки в Испании?","kind":"content"},{"text":"Лучшие клиники по иммунотерапии при раке почки в Испании — 6 проверенных вариантов с ценами","kind":"content"},{"text":"Обзор процедуры Иммунотерапия при раке почки в Испании","kind":"content"},{"text":"Получите медицинскую консультацию по иммунотерапии при раке почки в Испании: Выбирайте среди лучших специалистов в этой области","kind":"content"},{"text":"Видеоистории пациентов Bookimed","kind":"content"},{"text":"Отзывы о Bookimed: узнайте о реальном опыте пациентов","kind":"content"},{"text":"Поделитесь этим материалом","kind":"content"},{"text":"FAQ по иммунотерапии при раке почки в Испании","kind":"content"},{"text":"Получить бесплатную консультацию","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}